Clinical Trials Browser

Metastatic Pancreatic Adenocarcinoma × olaparib × Gastrointestinal × Clear all

NCT02677038 2024-10-01

Olaparib in Treating Patients With Stage IV Pancreatic Cancer

Phase 2 Completed

24 enrolled 8 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma